[PDF] from mja.com.auI Larmour, S Pignataro, KL Barned… - The Medical journal of …, 2011 - mja.com.au METHODS The TEP was introduced at SH in the 2006– 07 financial year, and we report findings to the 2009–10 financial year. It was approved by the Southern Health Therapeutics Com- mittee and the Southern Health Medical Executive Committee. Representatives from these ... Related articles - View as HTML - All 3 versions
PM Kondra, L Endrenyi… - Clinical Therapeutics, 2011 - Elsevier Advisory committees for the regulatory agencies of the United States (US Food and Drug Administration [FDA]) and Canada (Health Canada) recently considered issues associated with the determination of bioequivalence for some multiphasic modified-release (MR) drug products. The FDA ...
M Boh, G Opolski, P Poredosˇ, R Eska… - … angiology: a journal of …, 2011 - ncbi.nlm.nih.gov AIM.Generic drugs are more and more frequently used instead of originators. However, uncertainty exists with respect to therapeutic equivalence of generic product with originator one. Therefore, in this study efficacy and safety of generic atorvastatin was compared to ...
C Ahn - 응용통계연구, 2011 - papersearch.net ... protection. When the patent of an innovative (brand- name) small-molecule drug expires, generic copies of the innovative drug may be marketed if their therapeutic equivalence to the innovative drug has been shown. However ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
